The supply chain of cannabis extracts
According to published financial reports and investigation findings, international cannabis producer Curaleaf Holdings Inc. sells its extracts on the Ukrainian market. This process takes place through its Spanish subsidiary, Medalchemy S.L. In Ukraine, the official distributor is Ukrpharmgroup LLC, while Farmdistribution LLC obtained registration. It is worth noting that the history, financing and management of the parent company have a direct connection to Russia.
Key figures and ownership structure
The controlling voting stake in Curaleaf, amounting to 69.28%, belongs to the company’s chairman, Boris Jordan. This individual previously held the position of head of Gazprom-Media and president of the Russian Sputnik group, and also mentioned close personal relations with Putin.
Among the company’s significant shareholders is Andriy Blokh, former president of Sibneft, who is under Ukrainian sanctions. In addition, in autumn 2026, Ilya Grudev, who was born in Moscow, became the director of the Spanish subsidiary.
Financial links with sanctioned entities
Official reporting indicates that Curaleaf’s establishment was made possible by multi-million-dollar investments from Russian oligarch Roman Abramovich, who is also under sanctions. Moscow Credit Bank participated in the company’s share transactions, ended up under sanctions, and ultimately acquired 15.5 million Curaleaf shares.
Product status in Ukraine
Despite the parent structure’s financial and managerial background, three extracts from the Curaleaf brand have already been registered in Ukraine. They are intended for the production of prescription medicines, which are sold through the pharmacy network.
We hope that the facts presented will become the subject of thorough scrutiny by Ukrainian law enforcement agencies and regulatory bodies.
Comments
No comments yet. Be the first!